Method and device for radiotherapy
AssigneeAlthera Medical Ltd.
InventorsItzhak KELSON, Lior Arazi
Life of this patent
Estimating the term…
Abstract
A radiotherapy method, comprising positioning a predetermined amount of a radionuclide selected from the group consisting of Radium-223, Radium-224, Radon-219 and Radon-220, in proximity to and/or within a tumor of a subject, for a predetermined time period. The predetermined amount and the predetermined time period are selected sufficient for the radionuclide to administering a predetermined therapeutic dose of decay chain nuclei and alpha particles into the tumor.
Claims20
A method of manufacturing a radiotherapy device, the method comprising:
- providing a probe having a surface;
- positioning said surface in a flux of a radionuclide selected from the group consisting of Radium-223 and Radium-224;
- and
- collecting atoms of said radionuclide to retainably embed said atoms on or beneath said surface, and to ensure that said radionuclide remains in said probe while a therapeutic dose of decay chain nuclei and alpha particles of said radionuclide is emitted outside said surface, thereby manufacturing the radiotherapy device.
A method of preparing a radioactive surface source, the method comprising:
- providing a solution containing a predetermined amount of a radioactive isotope;
- and
- spreading said solution on a metal surface so as to provide an admixture of said metal and said solution, wherein a thickness of a said solution over said metal surface is sufficiently small to allow recoiling of decay chain nuclei resulting from alpha decay of said radioactive isotope out of said admixture, thereby providing said radioactive surface source.
Dependencies are inferred from the claim text.